PHASE I, DOSE-FINDING STUDY OF SUNITINIB (SU) IN COMBINATION WITH IRINOTECAN (IR) IN PATIENTS WITH ADVANCED SOLID TUMOURS

被引：0
|
作者：
Boven, E. [1 ]
Massard, C. [2 ]
Armand, J. P. [3 ]
Tillier, C. [1 ]
Hartog, V. [1 ]
Brega, N. M. [4 ]
Contouriotis, A. M. [5 ]
Law, C. N. J. [5 ]
Soria, J. [1 ]
机构：
[1] Vrije Univ Amsterdam, Med Ctr, Amsterdam, Netherlands
[2] Inst Gustave Roussy, Villejuif, France
[3] Inst Claudius Regaud, Toulouse, France
[4] Pfizer Global Res & Dev, Oncology, Milan, Italy
[5] Pfizer Inc, Global Res & Dev, La Jolla, CA USA
来源：
ANNALS OF ONCOLOGY | 2008年 / 19卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：156 / 157
页数：2
相关论文
共 50 条
  • [41] Phase I dose-finding study and a pharmacokinetic/pharmacodynamic analysis of the neutropenic response of intravenous diflomotecan in patients with advanced malignant tumours
    Trocòniz, IF
    Garrido, MJ
    Segura, C
    Cendrós, JM
    Principe, P
    Peraire, C
    Obach, R
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2006, 57 (06) : 727 - 735
  • [42] Phase I dose-escalation study of intravenous aflibercept administered in combination with irinotecan, 5-fluorouracil and leucovorin in patients with advanced solid tumours
    Van Cutsem, Eric
    Khayat, David
    Verslype, Chris
    Billemont, Bertrand
    Tejpar, Sabine
    Meric, Jean-Baptiste
    Soussan-Lazard, Karen
    Assadourian, Sylvie
    Cartot-Cotton, Sylvaine
    Rixe, Olivier
    EUROPEAN JOURNAL OF CANCER, 2013, 49 (01) : 17 - 24
  • [43] Phase 1 dose-finding and pharmacokinetic study of eribulin-liposomal formulation in patients with solid tumours
    Evans, T. R. Jeffry
    Dean, Emma
    Molife, L. Rhoda
    Lopez, Juanita
    Ranson, Malcolm
    El-Khouly, Fatima
    Zubairi, Ishtiaq
    Savulsky, Claudio
    Reyderman, Larisa
    Jia, Yan
    Sweeting, Lorna
    Greystoke, Alastair
    Barriuso, Jorge
    Kristeleit, Rebecca
    BRITISH JOURNAL OF CANCER, 2019, 120 (04) : 379 - 386
  • [44] Phase 1 dose-finding and pharmacokinetic study of eribulin-liposomal formulation in patients with solid tumours
    T. R. Jeffry Evans
    Emma Dean
    L. Rhoda Molife
    Juanita Lopez
    Malcolm Ranson
    Fatima El-Khouly
    Ishtiaq Zubairi
    Claudio Savulsky
    Larisa Reyderman
    Yan Jia
    Lorna Sweeting
    Alastair Greystoke
    Jorge Barriuso
    Rebecca Kristeleit
    British Journal of Cancer, 2019, 120 : 379 - 386
  • [45] A Phase I Dose-Finding Study of 5-Azacytidine in Combination with Sodium Phenylbutyrate in Patients with Refractory Solid Tumors
    Lin, Jianqing
    Gilbert, Jill
    Rudek, Michelle A.
    Zwiebel, James A.
    Gore, Steve
    Jiemjit, Anchalee
    Zhao, Ming
    Baker, Sharyn D.
    Ambinder, Richard F.
    Herman, James G.
    Donehower, Ross C.
    Carducci, Michael A.
    CLINICAL CANCER RESEARCH, 2009, 15 (19) : 6241 - 6249
  • [46] Phase I study of temsirolimus in combination with cetuximab in patients with advanced solid tumours
    Hollebecque, A.
    Bahleda, R.
    Faivre, L.
    Adam, J.
    Poinsignon, V.
    Paci, A.
    Gomez-Roca, C.
    Thery, J. C.
    Le Deley, M. C.
    Varga, A.
    Gazzah, A.
    Ileana, E.
    Gharib, M.
    Angevin, E.
    Malekzadeh, K.
    Massard, C.
    Soria, J. C.
    Spano, J. P.
    EUROPEAN JOURNAL OF CANCER, 2017, 81 : 81 - 89
  • [47] A Phase I, dose-finding and pharmacokinetic study of olaparib (AZD2281) in Japanese patients with advanced solid tumors*,†
    Yamamoto, Noboru
    Nokihara, Hiroshi
    Yamada, Yasuhide
    Goto, Yasushi
    Tanioka, Maki
    Shibata, Takashi
    Yamada, Kazuhiko
    Asahina, Hajime
    Kawata, Toshio
    Shi, Xiaojin
    Tamura, Tomohide
    CANCER SCIENCE, 2012, 103 (03) : 504 - 509
  • [48] Safety and tolerability of AZD8055 in Japanese patients with advanced solid tumors; a dose-finding phase I study
    Hajime Asahina
    Hiroshi Nokihara
    Noboru Yamamoto
    Yasuhide Yamada
    Yosuke Tamura
    Kazunori Honda
    Yoshitaka Seki
    Yuko Tanabe
    Hitoshi Shimada
    Xiaojin Shi
    Tomohide Tamura
    Investigational New Drugs, 2013, 31 : 677 - 684
  • [49] Phase I study of capecitabine in combination with cisplatin and irinotecan in patients with advanced solid malignancies
    H. Sayar
    Z. Shen
    S. J. Lee
    M. Royce
    I. Rabinowitz
    F. Lee
    H. Smith
    S. Eberhardt
    A. Maestas
    H. Lu
    C. Verschraegen
    Investigational New Drugs, 2009, 27 : 153 - 158
  • [50] A Phase I, Dose-Finding Study in Patients with Advanced Solid Malignancies of the Oral γ-Secretase Inhibitor PF-03084014
    Messersmith, Wells A.
    Shapiro, Geoffrey I.
    Cleary, James M.
    Jimeno, Antonio
    Dasari, Arvind
    Huang, Bo
    Shaik, M. Naveed
    Cesari, Rossano
    Zheng, Xianxian
    Reynolds, Jennifer M.
    English, Patricia A.
    McLachlan, Karen R.
    Kern, Kenneth A.
    LoRusso, Patricia M.
    CLINICAL CANCER RESEARCH, 2015, 21 (01) : 60 - 67
12345